The traditional APIs segment accounted for the largest share in 2024, whereas the HPAPI segment is expected to grow at the fastest CAGR over the forecast period. The HPAPI segment is further segmented ...

Indian drugmaker Alivus Life Sciences , formerly called Glenmark Life Sciences, reported a higher third-quarter profit on ...

The MarketWatch News Department was not involved in the creation of this content. WESTFORD, Mass., July 15, 2024 /PRNewswire/ -- According to SkyQuest, the global Active Pharmaceutical Ingredients ...

Plant-based Active Pharmaceutical Ingredients (APIs) Market · GlobeNewswire Inc. Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The "Plant-based Active Pharmaceutical Ingredients (APIs) - Global Strategic ...

DENVER, May 12, 2020 /PRNewswire/ -- KND Labs, a leading manufacturer of hemp-derived ingredients, has earned the accreditation of Active Pharmaceutical Ingredients (API), the company announced today.

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence ...

SAN FRANCISCO, April 29, 2025 /PRNewswire/ -- The global active pharmaceutical ingredients market size is projected to reach USD 359.45 billion by 2030, and it is expected to exhibit a CAGR of 5.85% ...

Protein aggregation and active principle ingredients (API) stability are factors that ultimately impact both the usability and quality of many biopharmaceutical products, especially injectables. The ...

The Sterile Dry Powder API Market is witnessing robust growth driven by the increasing adoption of injectable drugs, expansion of biologics manufacturing, and the rising prevalence of chronic diseases ...

ALBANY, New York, June 24, 2019 /PRNewswire/ -- According to the report by Transparency Market Research, the global active pharmaceutical ingredients market is projected to worth approximately ...

TEL AVIV, Israel--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active ...